Chrissy joined Lumanity as a health economist in 2010. In her tenure here, Chrissy’s role has evolved from technical delivery to project and team leadership, including time as Head of Health Economics Analysis, and later as Head of Modelling and Analytics. Chrissy is currently a Vice President in our Health Economics and Outcomes Research (HEOR) Consulting unit, providing leadership to our clients on proposals and projects involving economic modeling and health technology assessment (HTA) in the UK and Europe.
Chrissy has experience in leading and advising on health economic modeling and HTA submissions to the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC), the National Centre for Pharmacoeconomics (NCPE), and Tandvårds- och läkemedelsförmånsverket (TLV; Dental and Pharmaceutical Benefits Agency, Sweden), as well as projects involving early economic models, global economic models, and evidence generation.
Chrissy’s experience covers a broad range of indications; however, she has significant expertise and interest in the field of ophthalmology, having led and advised on HEOR projects across a wide range of ophthalmological indications.